Examining corruption risks in the procurement and distribution of COVID-19 vaccines in select states in Nigeria

References

• Hutchinson E, et al.Targeting anticorruption interventions at the front line: developmental governance in health systemsBMJ Glob Health2020512e003092 10.1136/bmjgh-2020-003092 33272939 7716661
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime. COVID-19 vaccines and corruption risks: preventing corruption in the manufacture, allocation and distribution of vaccines. City: United Nations; Year. https://www.unodc.org/documents/corruption/COVID-19/Policy_paper_on_COVID-19_vaccines_and_corruption_risks.pdf. Accessed 21 Nov 2022.
   Google Scholar
• Rose-Ackerman S. Corruption and COVID-19. EUNOMÍA. Revista en Cultura de la Legalidad. 2021;20:16–36.
   Google Scholar
• MJ Noon. How to stop vaccine corruption, which is plaguing the global fight against COVID-19. Fortune [Internet]. 2021. https://fortune.com/2021/08/14/covid-vaccine-corruption-distribution-rollout/. Accessed 29 Oct 2022.
   Google Scholar
• Onwujekwe O, et al. Exploring the nature, enabling factors and solutions to corruption in the procurement of pharmaceuticals in Nigeria tertiary health institutions: a qualitative study. ACE SOAS Consortium. 2022. https://ace.soas.ac.uk/wp-content/uploads/2022/05/ACE-WorkingPaper042-CorruptionPharmaProcurement.pdf. Accessed 1 Aug 2022.
   Google Scholar
• Kohler JC, Dimancesco DThe risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this riskGlob Health Action202013sup11694745 10.1080/16549716.2019.1694745 32194011 7170361
   PubMedGoogle Scholar
• Farzanegan MR, Hofmann HPEffect of public corruption on the COVID-19 immunization progressSci Rep202111123423 1:CAS:528:DC%2BB3MXis1Orur7L 10.1038/s41598-021-02802-1 34873212 8648879
   PubMed Web of Science ®Google Scholar
• Moosa M, Felton J, and Mpako A. South Africans support government's COVID-19 response but are critical of corruption and skeptical of vaccines. Afrobarometer. 2021. https://www.afrobarometer.org/wp-content/uploads/2022/02/ad467-south_africans_support_governments_covid-19_response_but_are_skeptical_of_vaccines-afrobarometer-27july21_1.pdf
   Google Scholar
• Fagbadebo O, Dorasamy NDorasamy NPandemic within pandemic: corruption as an impediment to effective management of COVID-19 in Nigeria and South AfricaGovernance challenges during the COVID-19 pandemic in Africa2022ChamSpringer253271 10.1007/978-3-031-11244-7_13
   Google Scholar
• Usman M, Husnain M, Akhtar MW, Ali Y, Riaz A, Riaz AFrom the COVID-19 pandemic to corrupt practices: a tale of two evilsEnviron Sci Pollut Res202229203029730310 10.1007/s11356-022-18536-0
   PubMed Web of Science ®Google Scholar
• Adepoju P. Nigeria receives COVID-19 vaccines amid confusion over rollout. Devex [Internet]. 2021. https://www.devex.com/news/nigeria-receives-covid-19-vaccines-amid-confusion-over-rollout-99298. Accessed 23 Jan 2023.
   Google Scholar
• Yusuf K. How Nigerian states, regions fare in COVID-19 vaccination. Premium Times [Internet]. 2023. https://www.premiumtimesng.com/news/headlines/575809-how-nigerian-states-regions-fare-in-covid-19-vaccination.html. Accessed 28 Apr 2023.
   Google Scholar
• Nigeria Centre for Disease Control. COVID-19 Nigeria. https://covid19.ncdc.gov.ng/. Accessed 28 Apr 2023.
   Google Scholar
• Spreco A, Schön T, Timpka TCorruption should be taken into account when considering COVID-19 vaccine allocationProc Natl Acad Sci202211919e2122664119 1:CAS:528:DC%2BB38XhtlymtrrP 10.1073/pnas.2122664119 35507880 9171641
   PubMed Web of Science ®Google Scholar
• Tong A, Sainsbury P, Craig JConsolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groupsInt J Qual Health Care2007196349357 10.1093/intqhc/mzm042 17872937
   PubMed Web of Science ®Google Scholar
• Neubauer B, Witkop C, Varpio LHow phenomenology can help us learn from the experiences of othersPerspect Med Educ201989097 10.1007/S40037-019-0509-2 30953335 6468135
   PubMed Web of Science ®Google Scholar
• de Bengy PA, Storeng KTCOVAX, vaccine donations and the politics of global vaccine inequityGlob Health2022181114
   PubMed Web of Science ®Google Scholar
• Hussmann K, Cuadrado DC, Kirya MGlobal access to COVID-19 vaccines: lifting the veil of opacityRelief Web2021202112139
   Google Scholar
• Human Rights Watch. Universal and equitable access to COVID-19 vaccines, testing, treatments: companies’ human rights responsibilities. New York: Human Rights Watch; 2021 [10th February 2023]. https://www.hrw.org/news/2021/02/11/universal-and-equitable-access-covid-19-vaccines-testing-treatments-companies-human. Accessed 10 Feb 2023.
   Google Scholar
• Nyabola N. Vaccine nationalism is patently unjust. The Nation [Internet]. 2021. https://www.thenation.com/article/world/coronavirus-vaccine-justice/. Accessed 22 Mar 2021.
   Google Scholar
• Agaba DKTackling inequality and governance challenges: Insights from the COVID-19 pandemicAfr Human Rights Law J2021212877906 10.17159/1996-2096/2021/v21n2a35
   Google Scholar
• Norman IDCommentary: ethnocentric considerations in the allocation of vaccines in AfricaEur J Med Health Sci2021328486
   Google Scholar
• Kashyap A and Wurth M. Rights key to tackle corruption, inequality in vaccine access. New York: Human Rights Watch. 2021. https://www.hrw.org/news/2021/03/11/rights-key-tackle-corruption-inequity-vaccine-access. Accessed 24 Apr 2023.
   Google Scholar
• Van De Pas R, et al.COVID-19 vaccine equity: a health systems and policy perspectiveExpert Rev Vaccines20222112536 10.1080/14760584.2022.2004125 34758678
   PubMed Web of Science ®Google Scholar
• Igwe M. Understanding how corruption impacted Nigeria’s COVID-19 response. Premium Times [Internet]. 2022. https://www.premiumtimesng.com/opinion/554049-understanding-how-corruption-impacted-nigerias-covid-19-response-by-uche-igwe.html. Accessed 24 Feb 2023.
   Google Scholar
• Federal Republic of Nigeria, Federal Ministry of Health, Department of Food and Drug Services. National vaccine policy. 1st ed [Internet]. City: Federal Republic of Nigeria; 2021. https://health.gov.ng/doc/Nigeria-Vaccine-Policy-2021.pdf. Accessed 03 Mar 2023.
   Google Scholar
• Chukwu OA, Nnogo CCSurmounting inherent challenges in healthcare service delivery for effective procurement and distribution of COVID-19 vaccines: a developing country contextHealth Policy Technol.2021102100518 10.1016/j.hlpt.2021.100518 34026475 8132497
   PubMed Web of Science ®Google Scholar
• Ripples Nigeria. Health workers still collect bribes, issue COVID-19 cards without vaccination. ed, 2022. https://www.ripplesnigeria.com/investigation-health-workers-still-collect-bribes-issue-covid-19-cards-without-vaccination/. Accessed 12 Feb 2022.
   Google Scholar
• Onwubiko H. COVID-19 jab: death, corruption and those Hallelujah men. ed, 2021. The Guardian [Internet]. 2021. https://guardian.ng/opinion/covid-19-jab-death-corruption-and-those-hallelujah-men/. Accessed 11 Feb 2023.
   Google Scholar
• The Sun. Mrs. Obiano’s courage in taking COVID-19 vaccine on live video commendable – Obigwe. The Sun [Internet]. 2021 https://www.sunnewsonline.com/mrs-obianos-courage-in-taking-covid19-vaccine-on-live-video-commendable-obigwe/. Accessed 25 Mar 2023.
   Google Scholar
• Kuza E. COVID-19 vaccinations in Nigeria: what are the implications for international NGOs? ed, 2021. GISF [Internet]. 2021 Jul 2, (2023 March 25) potentially accessed date and website if applicable) Available from: https://www.gisf.ngo/blogs/covid-19-vaccinations-in-nigeria-what-are-the-implications-for-international-ngos/. Accessed 25 Mar 2023.
   Google Scholar
• Steingrüber S and Gadanya M. Weak links: how corruption affects the quality and integrity of medical products and impacts on the COVID-19 response. U4 Anti-Corruption Resource Centre. 2021;15. https://www.u4.no/publications/weak-links-how-corruption-affects-the-quality-and-integrity-of-medical-products-and-impacts-on-the-covid-19-response.pdf
   Google Scholar
• Storeng KT, de Bengy Puyvallée A, and Stein F. COVAX and the rise of the “super public private partnership” for global health. Global Public Health. 2021; 1–17.
   Google Scholar
• Transparency International. Another shot at vaccine transparency: the week in corruption. City: Transparency International. 2021 Oct 25 https://www.transparency.org/en/blog/shot-at-vaccine-transparency-pfizer-covax. Accessed 24 Apr 2023.
   Google Scholar
• Amnesty International. COVAX: enhance transparency, share intellectual property. City: Amnesty International. 2021. https://www.amnesty.org/en/latest/press-release/2021/05/covax-enhance-transparency-share-intellectual-property/. Accessed 11 Mar 2023.
   Google Scholar
• Ezigbo O. How PTF plans to monitor COVID-19 vaccination campaign. https://www.thisdaylive.com/index.php/2021/03/18/how-ptf-plans-to-monitor-covid-19-vaccination-campaign. Accessed 15 Mar 2023.
   Google Scholar
• Olokor F. ICPC monitoring COVID-19 vaccine distribution to curb theft – NPHCDA. ed, 2021. Punch 2021. https://punchng.com/icpc-monitoring-covid-19-vaccine-distribution-to-curb-theft-nphcda/. Accessed 15 Mar 2023.
   Google Scholar
• Rahman K. Mitigating corruption risks in COVID-19 vaccine rollout: What can donors do? U4 Helpdesk Answer. 2021;7(2):1-26.
   Google Scholar
• So AD, Woo JAchieving path-dependent equity for global COVID-19 vaccine allocationMed202124373377 1:CAS:528:DC%2BB38XhvVGks7vL 10.1016/j.medj.2021.03.004 33758829
   PubMedGoogle Scholar
• Shackelford E. Could COVAX be used as a test case to demand more aid accountability in South Sudan? “The key to effective leverage is finding something those in charge covet.” The New Humanitarian [Internet]. 2021 Apr 12 [2023 May 05]. https://www.thenewhumanitarian.org/opinion/2021/4/12/could-covax-be-test-case-to-demand-aid-accountability-in-south-sudan. Accessed 05 May 2023.
   Google Scholar
• Goel RK, Nelson MADrivers of COVID-19 vaccinations: vaccine delivery and delivery efficiency in the United StatesNETNOMICS20212215369 10.1007/s11066-021-09148-w
   Web of Science ®Google Scholar
• Cushing J. Is the Sputnik V vaccine too good to be true? Without the data, it’s hard to know. StatNews. 2021. https://www.statnews.com/2021/05/26/data-needed-know-if-sputnik-v-vaccine-too-good-to-be-true/. Accessed 11 Mar 2023.
   Google Scholar
• Cushing J. The unspoken covid-19 vaccine challenges - distribution and corruption. Transparency International, United Kingdom. 2020. https://www.transparency.org.uk/coronavirus-covid-19-vaccine-equitable-distribution. Accessed 15 Apr 2023.
   Google Scholar
• Duho KC, Taylor A, Amamoo RS, Amamoo RS. COVID-19 Vaccination, Supply Chain and Concerns on Vaccine Hesitancy in Africa. The World Financial Review, September/October Edition. 2021:36–40.
   Google Scholar
• Dzinamarira T, Nachipo B, Phiri B, Musuka GCOVID-19 vaccine roll-out in South Africa and Zimbabwe: urgent need to address community preparedness, fears and hesitancyVaccines202193250 1:CAS:528:DC%2BB3MXhvFOhtLzI 10.3390/vaccines9030250 33809002 8000117
   PubMed Web of Science ®Google Scholar
• Hinson RE, Hein W, Tettey LN, Nartey BA, Harant A, Struck NS, Fobil JNCritical prerequisites for Covid-19 vaccine acceleration: a developing economy perspectiveJ Public Aff2021214 10.1002/pa.2723 34512185 8420375
   PubMed Web of Science ®Google Scholar
• Moodley K, Rossouw TWhat could fair allocation of an efficacious COVID-19 vaccine look like in South Africa?Lancet Glob Health202192e106e107 1:CAS:528:DC%2BB3sXislSrsrs%3D 10.1016/S2214-109X(20)30474-5 33160456
   PubMed Web of Science ®Google Scholar